Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from InfuSystem Holdings ( (INFU) ).
InfuSystem Holdings, Inc. announced it will release its second quarter 2025 financial results on August 5, 2025, before the market opens. The company will also host a conference call on the same day to discuss the financial results, providing stakeholders with insights into its financial performance and strategic direction.
The most recent analyst rating on (INFU) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on InfuSystem Holdings stock, see the INFU Stock Forecast page.
Spark’s Take on INFU Stock
According to Spark, TipRanks’ AI Analyst, INFU is a Neutral.
InfuSystem Holdings demonstrates impressive financial growth and strategic enhancements, including a robust earnings call and positive corporate events. However, high valuation poses a risk, and the technical analysis indicates neutral market sentiment.
To see Spark’s full report on INFU stock, click here.
More about InfuSystem Holdings
InfuSystem Holdings, Inc. is a leading national healthcare service provider that facilitates outpatient care for durable medical equipment manufacturers and healthcare providers. The company operates under a two-platform model: Patient Services, which includes Oncology, Pain Management, and Wound Therapy, and Device Solutions, which supports Patient Services with direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in Rochester Hills, Michigan, InfuSystem also operates Centers of Excellence in various locations across the United States and Canada.
Average Trading Volume: 193,216
Technical Sentiment Signal: Sell
Current Market Cap: $123.8M
See more insights into INFU stock on TipRanks’ Stock Analysis page.